Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 121

1.

Re: Axel Heidenreich, David Pfister. Treatment decisions for metastatic castration-resistant prostate cancer progressing after docetaxel chemotherapy: the role of cabazitaxel in the continuum of care. Eur Urol 2012;62:1201-4.

Brookman-May S, Tombal B, Joniau S.

Eur Urol. 2013 Sep;64(3):e62-4. doi: 10.1016/j.eururo.2013.03.056. Epub 2013 Apr 4. No abstract available.

PMID:
23582882
[PubMed - indexed for MEDLINE]
2.

Treatment decisions for metastatic castration-resistant prostate cancer progressing after docetaxel chemotherapy: the role of cabazitaxel in the continuum of care.

Heidenreich A, Pfister D.

Eur Urol. 2012 Dec;62(6):1201-4. doi: 10.1016/j.eururo.2012.08.048. Epub 2012 Aug 29. No abstract available.

PMID:
22964168
[PubMed - indexed for MEDLINE]
3.

Expert opinion on chemotherapy use in castration-resistant prostate cancer progressing after docetaxel.

Gallardo E, Arranz JÁ, Maroto JP, León LÁ, Bellmunt J.

Crit Rev Oncol Hematol. 2013 Nov;88(2):357-67. doi: 10.1016/j.critrevonc.2013.06.008. Epub 2013 Jul 16. Review.

PMID:
23867574
[PubMed - indexed for MEDLINE]
4.

Case report: responses to cabazitaxel in metastatic castration-resistant prostate cancer after extensive docetaxel treatment.

Guancial EA, Taplin ME.

Clin Genitourin Cancer. 2011 Dec;9(2):130-2. doi: 10.1016/j.clgc.2011.06.001. Epub 2011 Aug 3. No abstract available.

PMID:
21816687
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

[Cabazitaxel after docetaxel: a new option in metastatic castration-resistant prostate cancer].

Lheureux S, Joly F.

Bull Cancer. 2012 Sep;99(9):875-80. doi: 10.1684/bdc.2012.1617. French.

PMID:
22877855
[PubMed - indexed for MEDLINE]
6.

Cabazitaxel: a novel second-line treatment for metastatic castration-resistant prostate cancer.

Paller CJ, Antonarakis ES.

Drug Des Devel Ther. 2011 Mar 10;5:117-24. doi: 10.2147/DDDT.S13029. Review. Erratum in: Drug Des Devel Ther. 2011;5:183.

PMID:
21448449
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial.

de Bono JS, Oudard S, Ozguroglu M, Hansen S, Machiels JP, Kocak I, Gravis G, Bodrogi I, Mackenzie MJ, Shen L, Roessner M, Gupta S, Sartor AO; TROPIC Investigators.

Lancet. 2010 Oct 2;376(9747):1147-54. doi: 10.1016/S0140-6736(10)61389-X.

PMID:
20888992
[PubMed - indexed for MEDLINE]
8.

Cabazitaxel for the treatment of castration-resistant prostate cancer.

Agarwal N, Sonpavde G, Sartor O.

Future Oncol. 2011 Jan;7(1):15-24. doi: 10.2217/fon.10.168.

PMID:
21174534
[PubMed - indexed for MEDLINE]
9.

Overcoming chemotherapy resistance in prostate cancer.

Madan RA, Pal SK, Sartor O, Dahut WL.

Clin Cancer Res. 2011 Jun 15;17(12):3892-902. doi: 10.1158/1078-0432.CCR-10-2654.

PMID:
21680545
[PubMed - indexed for MEDLINE]
Free Article
10.

Chemotherapy-based treatment for castration-resistant prostate cancer.

Seruga B, Tannock IF.

J Clin Oncol. 2011 Sep 20;29(27):3686-94. doi: 10.1200/JCO.2010.34.3996. Epub 2011 Aug 15. Review. Erratum in: J Clin Oncol. 2011 Dec 20;29(36):4847. Dosage error in article text.

PMID:
21844499
[PubMed - indexed for MEDLINE]
11.

Second-line chemotherapy in metastatic docetaxel-resistant prostate cancer: a review.

Colloca G, Venturino A, Checcaglini F.

Med Oncol. 2012 Jun;29(2):776-85. doi: 10.1007/s12032-011-9855-6. Epub 2011 Feb 20. Review.

PMID:
21336988
[PubMed - indexed for MEDLINE]
12.

Metastatic castration-resistant prostate cancer: changing landscape with cabazitaxel.

Fernández O, Afonso J, Vázquez S, Campos B, Lázaro M, León L, Antón Aparicio LM.

Anticancer Drugs. 2014 Mar;25(3):237-43. doi: 10.1097/CAD.0000000000000045. Review.

PMID:
24217332
[PubMed - indexed for MEDLINE]
13.

Prostate cancer: cabazitaxel--the taxane of choice in the new mCRPC landscape?

Oudard S, Angelergues A.

Nat Rev Urol. 2014 Jul;11(7):370-2. doi: 10.1038/nrurol.2014.144. Epub 2014 Jun 24.

PMID:
24960604
[PubMed - indexed for MEDLINE]
14.

Prolonged therapy with cabazitaxel in an octogenarian with metastatic castration-resistant prostate cancer.

Pal SK, Stein CA.

Clin Genitourin Cancer. 2012 Dec;10(4):274-6. doi: 10.1016/j.clgc.2012.03.007. Epub 2012 May 9. No abstract available.

PMID:
22575202
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Critical appraisal of cabazitaxel in the management of advanced prostate cancer.

Pal SK, Twardowski P, Sartor O.

Clin Interv Aging. 2010 Dec 3;5:395-402. doi: 10.2147/CIA.S14570. Review.

PMID:
21152241
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Cabazitaxel: a guide to its use in hormone-refractory metastatic prostate cancer.

Keating GM.

Drugs Aging. 2013 May;30(5):359-65. doi: 10.1007/s40266-013-0078-8. Review.

PMID:
23532557
[PubMed - indexed for MEDLINE]
17.

Progression of metastatic castrate-resistant prostate cancer: impact of therapeutic intervention in the post-docetaxel space.

Sartor AO.

J Hematol Oncol. 2011 Apr 23;4:18. doi: 10.1186/1756-8722-4-18. Review.

PMID:
21513551
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Cabazitaxel for the treatment of prostate cancer.

Michielsen DP, Braeckman JG, Denis L.

Expert Opin Pharmacother. 2011 Apr;12(6):977-82. doi: 10.1517/14656566.2011.567268. Epub 2011 Mar 15. Review.

PMID:
21406025
[PubMed - indexed for MEDLINE]
19.

Cabazitaxel: more than a new taxane for metastatic castrate-resistant prostate cancer?

Mita AC, Figlin R, Mita MM.

Clin Cancer Res. 2012 Dec 15;18(24):6574-9. doi: 10.1158/1078-0432.CCR-12-1584. Epub 2012 Oct 22.

PMID:
23091116
[PubMed - indexed for MEDLINE]
Free Article
20.

Docetaxel reintroduction in patients with metastatic castration-resistant docetaxel-sensitive prostate cancer: a retrospective multicentre study.

Eymard JC, Oudard S, Gravis G, Ferrero JM, Theodore C, Joly F, Priou F, Krakowski I, Zannetti A, Thill L, Beuzeboc P.

BJU Int. 2010 Oct;106(7):974-8. doi: 10.1111/j.1464-410X.2010.09296.x. Epub 2010 Mar 9.

PMID:
20230389
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk